Abstract
Maintaining normal thyroid function is crucial in pregnancy, yet thyroid dysfunction and the presence of thyroid peroxidase antibodies (TPOAb) affect 0.5% to 18% of pregnant women. Here, we conducted a genome-wide association study (GWAS) of eight thyroid traits, including two thyroid-related hormones, four thyroid dysfunctions, and two thyroid autoimmunity measurements among 85,421 Chinese pregnant women to investigate the genetic basis of thyroid function during pregnancy. Our study identified 176 genetic loci, including 125 previously unknown genome-wide associations. Joint epidemiological and Mendelian randomization analyses revealed significant associations between the gestational thyroid phenotypes and gestational complications, birth outcomes, and later-age health outcomes. Specifically, genetically elevated thyroid-stimulating hormone (TSH) levels during pregnancy correlated with lower glycemic levels, reduced blood pressure, and longer gestational duration. Additionally, TPOAb and thyroid functions during pregnancy share genetic correlations with later-age thyroid and cardiac disorders. These findings provide novel insights into the genetic determinants of thyroid traits during pregnancy, which may lead to new therapeutics, early pre-diagnosis and preventive strategies starting from early adulthood.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by the Shenzhen Basic Research Foundation (20220818100717002), Guangdong Basic and Applied Basic Research Foundation (2022B1515120080), the National Natural Science Foundation of China (31900487, 82203291) and the Shenzhen Health Elite Talent Training Project. Computation of this study was supported by BrightWing High-performance Computing Platform, School of Public Health (Shenzhen) and the National Supercomputing Center in GuangZhou.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by the Ethics Committee of School of Public Health (Shenzhen), Sun Yat-Sen University (2021. No.8), as well as the Institutional Board of Shenzhen Baoan Women and Children Hospital (LLSC2021-04-01-10-KS) and Longgang District Maternity and Child Healthcare Hospital of Shenzhen City (LGFYYXLLL-2022-024). The study strictly adhered to regulations governing ethical considerations and personal data protection. Data collection was approved by the Human Genetic Resources Administration of China (HGRA
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
GWAS summary statistics for the eight thyroid traits investigated can be accessed through the GWAS catalog and GWAS Atlas upon publication, with approval from the Human Genetic Resources Administration of China (HGRAC) (ID: 2024BAT00834). Researchers can register and gain access to use data. Raw sequencing data have been deposited to the Genome Sequence Archive (GSA) for Human (https://ngdc.cncb.ac.cn/gsa-human/) at the BIG Data Center, Beijing Institute of Genomics, Chinese Academy of Sciences, under the BioProject accession number (GSA-Human: HRA006833), with approval from HGRAC (ID: XXX). In compliance with the regulations of the Ministry of Science and Technology of China, the raw sequencing data contain information unique to an individual and thus require controlled access. Researchers who are interested in collaboration are welcome to contact Siyang Liu (liusy99{at}mail.sysu.edu.cn).
